SEC Form 4 · accession 0001170362-15-000002

ARENA PHARMACEUTICALS INC · ARNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — EVP, General Counsel & Sec

Period of report

Mar 17, 2015

Accepted (ET)

Mar 18, 2015 · 5:45 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001080709

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Mar 17, 2015	M	65,302	$1.49	A	193,341	D
Common Stock	Mar 17, 2015	M	4,698	$1.81	A	198,039	D
Common Stock	Mar 17, 2015	S	70,000	$5.00	D	128,039	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Employee Stock Option (right to buy)^F2	$1.49	Mar 17, 2015	M	65,302	D	—	Mar 15, 2021	Common Stock	65,302	79,698	D
Employee Stock Option (right to buy)^F3	$1.81	Mar 17, 2015	M	4,698	D	—	Mar 19, 2022	Common Stock	4,698	495,302	D

F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person.
F2The options vested in four equal annual installments, beginning on March 15, 2012, and became exercisable once vested.
F3The options vest in four equal annual installments, and are exercisable once vested. The first and second installments became exercisable on March 19, 2013, and 2014, respectively, and the third and fourth installments vest on March 19, 2015, and 2016, respectively.